No Nod For Covaxin Yet, Final WHO Assessment On November 3

The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine. The technical advisory group will now meet on November 3 for a final assessment.

from Videos https://ift.tt/3nr6fxC